Skip to main content
Erschienen in: Cancer Causes & Control 7/2009

01.09.2009 | Original Paper

The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis

verfasst von: Petra Vojtechova, Richard M. Martin

Erschienen in: Cancer Causes & Control | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

There is a long-standing interest in finding whether allergic disorders cause or prevent cancer. We meta-analyzed associations of allergies with prostate, breast, and colorectal cancers. We searched MEDLINE, EMBASE, and Web of Science between 1966 and 2008 and eligible reference lists. A total of 16 observational studies were included. Meta-analyses revealed no evidence that asthma, hay fever, or ‘any allergy’ are associated with cancers of the breast (relative risk, RR = 0.93, 95% CI: 0.73–1.19 for asthma; 1.04, 0.94–1.16 for hay fever; 1.01, 0.94–1.08 for any allergy); prostate (RR = 0.93, 95% CI: 0.76–1.15 for asthma; 0.96, 0.87–1.05 for hay fever; 1.01, 0.87–1.17 for any allergy); or colorectum (RR = 0.95, 95% CI: 0.77–1.16 for asthma; 0.95, 0.86–1.05 for hay fever; 0.94, 0.85–1.04 for any allergy). There was a positive association of atopy (assessed by allergen-specific IgE or skin prick testing) with prostate cancer (RR = 1.43, 95% CI: 1.08–1.91), but not breast (1.18, 0.90–1.55) or colorectal (1.32, 0.69–2.53) cancers. There is little epidemiological support for the immune surveillance theory or antigenic stimulation theory in breast or colorectal carcinogenesis. The findings for prostate cancer warrant further investigation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Ure DM (1969) Negative association between allergy and cancer. Scott Med J 14(2):51–54PubMed Ure DM (1969) Negative association between allergy and cancer. Scott Med J 14(2):51–54PubMed
3.
Zurück zum Zitat Mackay WD (1966) The incidence of allergic disorders and cancer. Br J Cancer 20(3):434–437PubMed Mackay WD (1966) The incidence of allergic disorders and cancer. Br J Cancer 20(3):434–437PubMed
8.
Zurück zum Zitat Merrill RM, Isakson RT, Beck RE (2007) The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol 99(2):102–116PubMedCrossRef Merrill RM, Isakson RT, Beck RE (2007) The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol 99(2):102–116PubMedCrossRef
9.
Zurück zum Zitat Wang H, Rothenbacher D, Low M, Stegmaier C, Brenner H, Diepgen TL (2006) Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer 119(3):695–701. doi:10.1002/ijc.21883 PubMedCrossRef Wang H, Rothenbacher D, Low M, Stegmaier C, Brenner H, Diepgen TL (2006) Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer 119(3):695–701. doi:10.​1002/​ijc.​21883 PubMedCrossRef
10.
Zurück zum Zitat Brandes LJ, Warrington RC, Arron RJ et al (1994) Enhanced Cancer Growth in Mice Administered Daily Human-Equivalent Doses of Some H1-Antihistamines: Predictive In Vitro Correlates. J Natl Cancer Inst 86(10):770–775. doi:10.1093/jnci/86.10.770 PubMedCrossRef Brandes LJ, Warrington RC, Arron RJ et al (1994) Enhanced Cancer Growth in Mice Administered Daily Human-Equivalent Doses of Some H1-Antihistamines: Predictive In Vitro Correlates. J Natl Cancer Inst 86(10):770–775. doi:10.​1093/​jnci/​86.​10.​770 PubMedCrossRef
13.
Zurück zum Zitat Tennis P, Sherrill B, Fernandez C, Dolan C (2005) Cancer risk in asthmatic populations. Ann Allergy Asthma Immunol 95(4):354–360PubMed Tennis P, Sherrill B, Fernandez C, Dolan C (2005) Cancer risk in asthmatic populations. Ann Allergy Asthma Immunol 95(4):354–360PubMed
15.
Zurück zum Zitat Sterne JAC, Egger M, Davey Smith G (2001) Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publishing Group, London, pp 189–208 Sterne JAC, Egger M, Davey Smith G (2001) Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publishing Group, London, pp 189–208
16.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634PubMed Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634PubMed
20.
Zurück zum Zitat Mills PK, Beeson WL, Fraser GE, Phillips RL (1992) Allergy and cancer: organ site-specific results from the Adventist Health Study. Am J Epidemiol 136(3):287–295PubMed Mills PK, Beeson WL, Fraser GE, Phillips RL (1992) Allergy and cancer: organ site-specific results from the Adventist Health Study. Am J Epidemiol 136(3):287–295PubMed
21.
Zurück zum Zitat Kallen B, Gunnarskog J, Conradson TB (1993) Cancer risk in asthmatic subjects selected from hospital discharge registry. Eur Respir J 6(5):694–697PubMed Kallen B, Gunnarskog J, Conradson TB (1993) Cancer risk in asthmatic subjects selected from hospital discharge registry. Eur Respir J 6(5):694–697PubMed
22.
Zurück zum Zitat Deeks JJ, Altman DG, Bradburn MJ (2003) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publishing Group, London, pp 285–312 Deeks JJ, Altman DG, Bradburn MJ (2003) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publishing Group, London, pp 285–312
23.
25.
Zurück zum Zitat Vena JE, Bona JR, Byers TE, Middleton E Jr, Swanson MK, Graham S (1985) Allergy-related diseases and cancer: an inverse association. Am J Epidemiol 122(1):66–74PubMed Vena JE, Bona JR, Byers TE, Middleton E Jr, Swanson MK, Graham S (1985) Allergy-related diseases and cancer: an inverse association. Am J Epidemiol 122(1):66–74PubMed
26.
Zurück zum Zitat Tobias A (1999) Assessing the influence of a single study in meta-analysis estimate. Stata Tech Bull 8(47):15–17 Tobias A (1999) Assessing the influence of a single study in meta-analysis estimate. Stata Tech Bull 8(47):15–17
27.
Zurück zum Zitat La VC, D’Avanzo B, Negri E, Franceschi S (1991) History of selected diseases and the risk of colorectal cancer. Eur J Cancer 27(5):582–586 La VC, D’Avanzo B, Negri E, Franceschi S (1991) History of selected diseases and the risk of colorectal cancer. Eur J Cancer 27(5):582–586
29.
Zurück zum Zitat Petroianu A, Chaves DN, De Oliveira O (1995) Comparative incidence of allergy in the presence or absence of cancer. J Int Med Res 23(5):358–363PubMed Petroianu A, Chaves DN, De Oliveira O (1995) Comparative incidence of allergy in the presence or absence of cancer. J Int Med Res 23(5):358–363PubMed
30.
Zurück zum Zitat Markowe HL, Bulpitt CJ, Shipley MJ, Rose G, Crombie DL, Fleming DM (1987) Prognosis in adult asthma: a national study. Br Med J Clin Res Ed 295(6604):949–952PubMedCrossRef Markowe HL, Bulpitt CJ, Shipley MJ, Rose G, Crombie DL, Fleming DM (1987) Prognosis in adult asthma: a national study. Br Med J Clin Res Ed 295(6604):949–952PubMedCrossRef
33.
Zurück zum Zitat Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia Rodriguez LA (2006) Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf 15(2):131–138. doi:10.1002/pds.1163 PubMedCrossRef Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia Rodriguez LA (2006) Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf 15(2):131–138. doi:10.​1002/​pds.​1163 PubMedCrossRef
34.
Zurück zum Zitat Talbot-Smith A, Fritschi L, Divitini ML, Mallon DF, Knuiman MW (2003) Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol 157(7):606–612. doi:10.1093/aje/kwg020 PubMedCrossRef Talbot-Smith A, Fritschi L, Divitini ML, Mallon DF, Knuiman MW (2003) Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol 157(7):606–612. doi:10.​1093/​aje/​kwg020 PubMedCrossRef
38.
Zurück zum Zitat Kune GA, Kune S, Watson LF (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48(15):4399–4404PubMed Kune GA, Kune S, Watson LF (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48(15):4399–4404PubMed
39.
Zurück zum Zitat McCarron SL, Edwards S, Evans PR et al (2002) Influence of Cytokine Gene Polymorphisms on the Development of Prostate Cancer. Cancer Res 62(12):3369–3372PubMed McCarron SL, Edwards S, Evans PR et al (2002) Influence of Cytokine Gene Polymorphisms on the Development of Prostate Cancer. Cancer Res 62(12):3369–3372PubMed
40.
Zurück zum Zitat Zheng SL, Liu W, Wiklund F et al (2006) A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study. Prostate 66(14):1556–1564. doi:10.1002/pros.20496 PubMedCrossRef Zheng SL, Liu W, Wiklund F et al (2006) A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study. Prostate 66(14):1556–1564. doi:10.​1002/​pros.​20496 PubMedCrossRef
Metadaten
Titel
The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis
verfasst von
Petra Vojtechova
Richard M. Martin
Publikationsdatum
01.09.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 7/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9334-y

Weitere Artikel der Ausgabe 7/2009

Cancer Causes & Control 7/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.